Access to abortion pills and other reproductive services will have another contentious year in 2026 across state legislatures as the Trump administration is expected to slow-walk further action. Criminalization of providers, reclassifying abortion drugs as controlled substances, and in-person dispensing requirements are among the issues percolating in legislatures across the US. At the federal ...
Source